FOXO4-DRI 10MG FOR SALE

Description

FOXO4-DRI 10mg is a high-purity research peptide widely studied in the field of cellular senescence, aging biology, and longevity science. As a modified D-retro-inverso (DRI) peptide derived from a region of the FOXO4 protein, it has gained significant scientific attention for its potential role in modulating senescent cell pathways and supporting advanced research into age-related cellular dysfunction.

Cellular senescence is a biological process in which cells lose their ability to divide and function properly while remaining metabolically active. These senescent cells are associated with inflammation, tissue aging, and reduced regenerative capacity. FOXO4-DRI has become a major focus of research due to its interaction with FOXO4-p53 signaling pathways, which are involved in the survival and maintenance of senescent cells in experimental models.

One of the primary areas of interest for FOXO4-DRI 10mg is its role in senescence-targeting research. Scientific studies have explored how the peptide may influence the interaction between FOXO4 and p53 proteins within senescent cells. This interaction is believed to play a role in cellular survival mechanisms. By investigating this pathway, researchers aim to better understand how senescent cells persist and how they may be selectively targeted in experimental aging models.

FOXO4-DRI is also widely studied in longevity and anti-aging research. The accumulation of senescent cells is strongly associated with age-related tissue decline and inflammatory signaling. Researchers continue to explore how modulation of senescence-related pathways may contribute to improved cellular function, tissue regeneration, and overall biological resilience in preclinical studies. This has made FOXO4-DRI a highly relevant compound in modern geroscience research.

Another important area of investigation involves inflammatory signaling pathways. Senescent cells are known to secrete pro-inflammatory factors collectively referred to as the senescence-associated secretory phenotype (SASP). This contributes to chronic low-grade inflammation observed in aging tissues. FOXO4-DRI is studied for its potential role in helping researchers understand how senescent cell signaling influences broader inflammatory environments within biological systems.

FOXO4-DRI is also included in studies focused on tissue regeneration and cellular turnover. By examining how senescent cells affect surrounding healthy tissue, researchers aim to better understand regenerative limitations in aging organisms. This peptide provides a useful tool for investigating how cellular senescence impacts repair mechanisms and tissue homeostasis.

The 10mg formulation of FOXO4-DRI is designed for precision research applications, offering a consistent and reliable concentration suitable for controlled laboratory environments. High purity and strict manufacturing standards ensure stability, reproducibility, and accuracy across experimental conditions. Each vial contains 10mg of FOXO4-DRI, making it suitable for a wide range of cellular biology and aging research protocols.

As interest in senescence biology continues to expand, FOXO4-DRI remains one of the most widely discussed peptides in aging and longevity research. Its connection to FOXO4-p53 signaling pathways and its relevance to senescent cell behavior have made it a key compound in experimental geroscience.

For researchers seeking a high-quality peptide for advanced studies in cellular senescence, aging mechanisms, and longevity science, FOXO4-DRI 10mg represents a reliable and scientifically significant option. Its strong research foundation and relevance to senescence pathways continue to make it a leading compound in modern peptide-based aging research.